A re-evaluation of the role of inhaled corticosteroids in the management of patients with chronic obstructive pulmonary disease
| dc.contributor.author | D'Urzo, Anthony | |
| dc.contributor.author | Donohue, James F | |
| dc.contributor.author | Kardos, Peter | |
| dc.contributor.author | Miravitlles, Marc | |
| dc.contributor.author | Price, David | |
| dc.contributor.institution | University of Aberdeen.Other Applied Health Sciences | en |
| dc.contributor.institution | University of Aberdeen.Institute of Applied Health Sciences | en |
| dc.date.accessioned | 2016-01-28T10:19:06Z | |
| dc.date.available | 2016-01-28T10:19:06Z | |
| dc.date.issued | 2015 | |
| dc.description.status | Peer reviewed | en |
| dc.format.extent | 16 | |
| dc.format.extent | 723064 | |
| dc.identifier | 54731025 | |
| dc.identifier | c1479561-2930-4bd5-9c9b-12b2c97ef57c | |
| dc.identifier | 26194213 | |
| dc.identifier | 84937721581 | |
| dc.identifier.citation | D'Urzo, A, Donohue, J F, Kardos, P, Miravitlles, M & Price, D 2015, 'A re-evaluation of the role of inhaled corticosteroids in the management of patients with chronic obstructive pulmonary disease', Expert Opinion on Pharmacotherapy, vol. 16, no. 12, pp. 1845-1860. https://doi.org/10.1517/14656566.2015.1067682 | en |
| dc.identifier.doi | 10.1517/14656566.2015.1067682 | |
| dc.identifier.iss | 12 | en |
| dc.identifier.uri | http://hdl.handle.net/2164/5448 | |
| dc.identifier.vol | 16 | en |
| dc.language.iso | eng | |
| dc.relation.ispartof | Expert Opinion on Pharmacotherapy | en |
| dc.subject | chronic obstructive pulmonary disease | en |
| dc.subject | inhaled corticosteroid | en |
| dc.subject | long-acting muscarinic antagonist | en |
| dc.subject | long-acting β2-agonist | en |
| dc.subject | RM Therapeutics. Pharmacology | en |
| dc.subject.lcc | RM | en |
| dc.title | A re-evaluation of the role of inhaled corticosteroids in the management of patients with chronic obstructive pulmonary disease | en |
| dc.type | Journal item | en |